Adult control data
| Control group | Mean (range) ASOT IU/ml | ABGA ELISA (mean, 95% CI) | Percentage of controls ABGA positive (antigen) |
|---|---|---|---|
| *This group includes patients with multiple sclerosis (n = 12), dementia (n = 7), paraneoplastic syndromes (n = 3), autoimmune neuropathy (n = 3), acute cerebellitis (n = 3), and other mixed neurological diseases (n = 22). †This group includes patients with blepharospasm (n = 10), DYT1 dystonia (n = 8), idiopathic Parkinson’s disease (n = 4), and Huntington’s disease (n = 1). | |||
| ASOT, anti-streptolysin O titres; ABGA, anti-basal ganglia antibodies; CI, confidence interval; ELISA, enzyme linked immunosorbent assay. | |||
| Healthy adults (n = 50) | 122 (50–376) | 0.28 (0.26 to 0.30) | 2% (55 kDa) |
| Neurology adults (n = 50)* | 140 (50–1210) | 0.22 (0.19 to 0.25) | 0 |
| Movement disorder adults (n = 23)† | 194 (50–352) | 0.30 (0.27 to 0.33) | 8% (36, 40 kDa) |